VIVS PE Ratio & Valuation, Is VIVS Overvalued

Historical Valuation

VivoSim Labs Inc (VIVS) is now in the Fair zone, suggesting that its current forward PS ratio of 21.13 is considered Fairly compared with the five-year average of -0.24. The fair price of VivoSim Labs Inc (VIVS) is between 1.17 to 2.29 according to relative valuation method.

Relative Value

Fair Zone

1.17-2.29

Current Price：1.86

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is VivoSim Labs Inc (VIVS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

VivoSim Labs Inc (VIVS) has a current Price-to-Book (P/B) ratio of 0.69. Compared to its 3-year average P/B ratio of 1.84, the current P/B ratio is approximately -62.35% higher. Relative to its 5-year average P/B ratio of 1.84, the current P/B ratio is about -62.35% higher. VivoSim Labs Inc (VIVS) has a Forward Free Cash Flow (FCF) yield of approximately -207.10%. Compared to its 3-year average FCF yield of -209.05%, the current FCF yield is approximately -0.94% lower. Relative to its 5-year average FCF yield of -209.05%, the current FCF yield is about -0.94% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for VIVS competitors is 4.23, providing a benchmark for relative valuation. VivoSim Labs Inc Corp (VIVS.O) exhibits a P/S ratio of 21.13, which is 400% above the industry average. Given its robust revenue growth of 8.33%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of VIVS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of VIVS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is VIVS currently overvalued or undervalued?

What is VivoSim Labs Inc (VIVS) fair value?

VIVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of VivoSim Labs Inc (VIVS) is between 1.17 to 2.29 according to relative valuation method.

How does VIVS's valuation metrics compare to the industry average?

The average P/S ratio for VIVS's competitors is 4.23, providing a benchmark for relative valuation. VivoSim Labs Inc Corp (VIVS) exhibits a P/S ratio of 21.13, which is 400.00% above the industry average. Given its robust revenue growth of 8.33%, this premium appears unsustainable.

What is the current P/B ratio for VivoSim Labs Inc (VIVS) as of Mar 13 2026?

As of Mar 13 2026, VivoSim Labs Inc (VIVS) has a P/B ratio of 0.69. This indicates that the market values VIVS at 0.69 times its book value.

What is the current FCF Yield for VivoSim Labs Inc (VIVS) as of Mar 13 2026?

As of Mar 13 2026, VivoSim Labs Inc (VIVS) has a FCF Yield of -207.10%. This means that for every dollar of VivoSim Labs Inc's market capitalization, the company generates -207.10 cents in free cash flow.

What is the current Forward P/E ratio for VivoSim Labs Inc (VIVS) as of Mar 13 2026?

As of Mar 13 2026, VivoSim Labs Inc (VIVS) has a Forward P/E ratio of -0.21. This means the market is willing to pay $-0.21 for every dollar of VivoSim Labs Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for VivoSim Labs Inc (VIVS) as of Mar 13 2026?

As of Mar 13 2026, VivoSim Labs Inc (VIVS) has a Forward P/S ratio of 21.13. This means the market is valuing VIVS at $21.13 for every dollar of expected revenue over the next 12 months.

VIVS Valuation